By Sneha S K and Sriparna Roy (Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes,​ including a potential sale, and warned it could launch a proxy fight if no progress ‌is made in the next four months. In a second letter to Novavax's board in less than a month, shared exclusively with ‌Reuters on Wednesday, Shah Capital said it has become "increasingly disenchanted" with the company's weak COVID-19 vaccine sales.

Connections are a basic piece of human existence, and they come in different structures \u2014 companionships, family bonds, heartfelt organizations, from there, the sky is the limit.

Israel's military said it again attacked targets of the Iranian-backed Hezbollah militia in the Lebanese capital Beirut on Sunday, with witnesses reporting five heavy bombardments in the southern suburbs of Dahiyeh. Lebanon's Health Ministry reported four dead and dozens injured.